Published in World J Mens Health on April 01, 2017
Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab (2001) 7.53
Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care (2004) 3.07
The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn (2002) 2.46
Nocturia in relation to sleep, somatic diseases and medical treatment in the elderly. BJU Int (2002) 2.06
The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag (2009) 1.90
Is nocturia equally common among men and women? A population based study in Finland. J Urol (2006) 1.64
The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol (2007) 1.58
Relationship of sex hormones and nocturia in lower urinary tract symptoms induced by benign prostatic hyperplasia. Aging Male (2012) 1.46
Nocturnal polyuria and decreased serum testosterone: is there an association in men with lower urinary tract symptoms? Int J Urol (2013) 1.42
Impact of nocturia on bone fracture and mortality in older individuals: a Japanese longitudinal cohort study. J Urol (2010) 1.42
Can treatment of nocturia increase testosterone level in men with late onset hypogonadism? Urology (2014) 1.40
Overactivity and structural changes in the chronically ischemic bladder. J Urol (1999) 1.35
The association of testosterone levels with overall sleep quality, sleep architecture, and sleep-disordered breathing. J Clin Endocrinol Metab (2008) 1.29
Erectile dysfunction and lower urinary tract symptoms secondary to BPH. Eur Urol (2005) 1.26
Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia. BJU Int (2003) 1.25
The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab (2003) 1.12
Prevalence of and risk factors for nocturia: Analysis of a health screening program. Int J Urol (2004) 1.10
Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study. Aging Male (2010) 1.06
Epidemiologic survey of lower urinary tract symptoms in Japan. Urology (2006) 1.05
Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment. Asian J Androl (2014) 1.05
Estrogen receptor-beta mediates dihydrotestosterone-induced stimulation of the arginine vasopressin promoter in neuronal cells. Endocrinology (2007) 1.02
Nocturia in relation to somatic health, mental health and pain in adult men and women. BJU Int (2005) 1.00
Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study. Aging Male (2008) 0.99
The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism. Aging Male (2008) 0.97
Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male (2015) 0.97
Persistent detrusor overactivity after transurethral resection of the prostate is associated with reduced perfusion of the urinary bladder. BJU Int (2007) 0.95
Impact of nocturia on health-related quality of life and medical outcomes study sleep score in men. Int Neurourol J (2011) 0.93
Disruption of the nocturnal testosterone rhythm by sleep fragmentation in normal men. J Clin Endocrinol Metab (2001) 0.93
A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate. J Androl (2007) 0.92
Late-onset hypogonadism syndrome and lower urinary tract symptoms. Korean J Urol (2011) 0.91
The relationship between sleep disorders and testosterone in men. Asian J Androl (2014) 0.90
Reproductive hormone replacement alters sleep in mice. Neurosci Lett (2009) 0.90
Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients. Aging Male (2010) 0.89
Testosterone therapy and obstructive sleep apnea: is there a real connection? J Sex Med (2007) 0.84
Serum testosterone levels significantly correlate with nocturia in men aged 40-79 years. Urology (2011) 0.84
Sleep timing may modulate the effect of sleep loss on testosterone. Clin Endocrinol (Oxf) (2012) 0.82
Testosterone replacement alone for testosterone deficiency syndrome improves moderate lower urinary tract symptoms: one year follow-up. World J Mens Health (2013) 0.82
Influence of paradoxical sleep deprivation and sleep recovery on testosterone level in rats of different ages. Asian J Androl (2011) 0.80
Correlation between Nocturia and Sleep: A Questionnaire Based Analysis. Korean J Urol (2010) 0.78
Effects of testosterone on the rat renal medullary vasopressin receptor concentration and the antidiuretic response. Life Sci (1995) 0.78
Effects of testosterone replacement therapy on nocturia and quality of life in men with hypogonadism: a subanalysis of a previous prospective randomized controlled study in Japan. Aging Male (2015) 0.78
Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters. Aging Male (2016) 0.77
Nocturia indicates a poor health status and increases mortality in male patients with type 2 diabetes mellitus. Int Urol Nephrol (2016) 0.77
Testosterone treatment restores reduced vasopressin-binding sites in the kidney of the ageing rat. J Endocrinol (1989) 0.77
Testosterone normalizes plasma vasopressin response to osmotic stimuli in men with hypogonadism. Endocr J (1993) 0.76
A possible relationship between serum sex hormones and benign prostatic hyperplasia/lower urinary tract symptoms in men who underwent transurethral prostate resection. Asian J Androl (2016) 0.76
Relationship between serum testosterone and nocturia in men without benign prostate enlargement. Andrology (2016) 0.76
Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer. Oncotarget (2016) 0.92
The relationship between prostate-specific antigen and TNM classification or Gleason score in prostate cancer patients with low prostate-specific antigen levels. Prostate (2015) 0.91
Chronological Urodynamic Evaluation of Changing Bladder and Urethral Functions After Robot-assisted Radical Prostatectomy. Urology (2015) 0.80
Use of preoperative factors including urodynamic evaluations and nerve-sparing status for predicting urinary continence recovery after robot-assisted radical prostatectomy: Nerve-sparing technique contributes to the reduction of postprostatectomy incontinence. Neurourol Urodyn (2015) 0.79
Investigating Urinary Conditions Prior to Robot-assisted Radical Prostatectomy in Search of a Desirable Method for Evaluating Post-prostatectomy Incontinence. Anticancer Res (2016) 0.78
Lower Urinary Tract Symptoms are Associated with Erectile Function and Psychological Symptoms in Men with Late-Onset Hypogonadism Syndrome. Low Urin Tract Symptoms (2013) 0.78
Massive Ascites in a Renal Transplant Patient after Laparoscopic Fenestration of a Lymphocele. Case Rep Transplant (2016) 0.75
Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 axis. Oncotarget (2017) 0.75
Therapies for castration-resistant prostate cancer in a new era: The indication of vintage hormonal therapy, chemotherapy and the new medicines. Int J Urol (2017) 0.75
Both High and Low Serum Total Testosterone Levels Indicate Poor Prognosis in Patients with Prostate Cancer. Anticancer Res (2017) 0.75
Human papillomavirus prevalence in the anus and urine among HIV-infected Japanese men who have sex with men. J Infect Chemother (2017) 0.75
Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naïve prostate cancer. Prostate (2015) 0.75
Evaluation of Factors Affecting Metastasis for Renal Cell Carcinoma Based on Current Guidelines in Japan. Anticancer Res (2017) 0.75
Changes in penile length after radical prostatectomy: investigation of the underlying anatomical mechanism. BJU Int (2017) 0.75
Metastasectomy Improves Survival in Patients with Metastatic Urothelial Carcinoma. Anticancer Res (2016) 0.75
An unusual prostate-specific antigen decrease in an advanced castration-resistant prostate cancer patient with intracerebral hemorrhage subsequently treated with luteinizing hormone-releasing hormone antagonist. Case Rep Nephrol Urol (2013) 0.75
Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma. Anticancer Res (2016) 0.75